** Shares of pet vaccine maker Elanco Animal Health ELAN.N rise 3.9% to $25.24 premarket
** Piper Sandler upgrades stock rating to "overweight" from "neutral", and raises PT to $30 from $24
** New PT implies an upside of 23.5% from stock's last close
** Elanco has made significant progress with corporate veterinary groups and practice owners, with corporate accounts now ranking the company as their second-choice vendor partner, up from a distant fourth, says brokerage
** "Elanco is making some serious inroads with corporate groups, which previous checks have found they were abysmal" - Piper Sandler
** 14 of 16 brokerages rate the stock "buy" or higher, two "hold"; median PT is $25 - data compiled by LSEG
** Shares up 86.7% in 2025, vs a 15% increase in NYSE Composite .NYA index
(Reporting by Ragini Mathur in Bengaluru)
((Ragini.Mathur@thomsonreuters.com;))
Comments